-
Net migration to the UK dropped 69% to 204,000 in the year to June 2025, the lowest since 2021, driven by fewer non-EU arrivals for work and study and increased emigration. Despite this, public concern over immigration remains high, especially regarding illegal Channel crossings and asylum seekers. The government has introduced stricter immigration policies and plans further reforms to reduce migration pressures.
-
As of late September 2025, new Alzheimer’s drugs like lecanemab and donanemab show promise in slowing disease progression but require early diagnosis and carry risks. The UK’s NHS and Australia face challenges in access and funding, while the UAE highlights the need for improved awareness and infrastructure. Meanwhile, the UK’s rollout of weight-loss drug Mounjaro is underfunded, limiting patient access amid rising demand and GP shortages.
-
Recent reports reveal worsening health conditions in Scotland, including record-high long-term illnesses and obesity, alongside declining national belonging among younger Australians. Meanwhile, workplace and social drinking habits are shifting globally, with younger generations drinking less or abstaining, yet facing peer pressure and cultural challenges. These trends highlight ongoing public health and social issues.
-
Recent reports highlight that global climate efforts are falling behind, with adaptation funding slowing and overshoot becoming inevitable. Experts warn of catastrophic impacts if emissions are not drastically reduced, emphasizing the urgency of immediate action ahead of COP30 in Brazil.
-
Retailers in the UK are cautious ahead of the November 26 Budget, fearing tax hikes and economic uncertainty. Industry leaders warn that upcoming fiscal policies could slow consumer spending, with recent cost increases already impacting profits and prices. Meanwhile, supply chain pressures and inflation persist across sectors.